Antibodies directed to the C-terminal side of β-amyloid peptide and methods of using these antibodies for diagnosing and treatment of Alzheimer's disease and Aβ peptide associated diseases are described. ...http://www.google.fr/patents/US20060292152?utm_source=gb-gplus-shareBrevet US20060292152 - Antibodies directed against amyloid-beta peptide and methods using same
Antibodies directed against amyloid-beta peptide and methods using same
Numéro de demande: 11/413,817 Numéro de publication: US 2006/0292152 A1 Date de dépôt: 28 avr. 2006 Brevet délivré: US7763250 ( Date de délivrance 27 juil. 2010)
